℘℘℘
In this age of skepticism, it’s reassuring to know that at least two cherished American myths – Horatio Alger s model of the self-made man and the image of the visionary inventor tinkering in his garage – still exist in the person of Dr. Thomas J. Fogarty. This renowned Irish-American heart surgeon, who started his inventing career as a boy in Cincinnati, is responsible for devices that have revolutionized cardiovascular surgery over the past four decades. His products are credited with making such surgery less threatening to the lives of tens of millions of people.
Fogarty’s first medical invention, the Fogarty… Arterial
Published: Apr 23, 2021
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) CareDx, Inc., Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced experts will present its latest heart research, which was accepted at the International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, set to take place between April 24-28, 2021.
CareDx’s offerings are showcased through 22 abstracts throughout the ISHLT program. These data selected by the ISHLT organizers, will be presented by prominent thought leaders, highlighting the continued leadership in the cardiothoracic space. Additionally, a CareDx symposium will spotlight leaders in the field of heart and lung transplantation delivering cutting edge content on HeartCare, AlloMap
From Too Risky to Last Resort, COVID-Related Organ Transplants Are Surging
Mark Buchanan from Roopville, GA didn’t think he was going to survive the COVID-19 pandemic. He and his entire family came down with a nasty bout of the disease, but no one wound up in the hospital except him. He was on a ventilator, sedated for nearly three months before starting extracorporeal membrane oxygenation (ECMO), a last-resort effort to save patients dying of the disease.
“They said that it had ruined my lungs,” Buchanan said. “The vent and the covid ruined ’em completely.”
However, his luck changed after becoming one of the first people in the U.S. to receive what’s being referred to as a COVID-related transplant. He received a double lung transplant in October at a time when few hospitals were willing to take a chance on the procedure. Now, these kinds of transplants are soaring all over the country.